Search research articles
Contact Us
Filters
Showing results (41-50 of 211) with videos related to
Page
of 22
Sort By:
Lancet (London, England)
|
November 19, 1988
Aspirin and fibrinolysis
A Basinski, C D Naylor
Pharmacoeconomics
|
March 9, 1994
Drug prices and third party payment: do they influence medication selection?
J E Hux, C D Naylor
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 1, 1995
Reflections on supply-demand mismatch in dialysis services in Ontario
N K Choudhry, C D Naylor
The Canadian Journal of Cardiology
|
September 1, 1995
Regional revascularization patterns after myocardial infarction in Ontario
C D Naylor, S B Jaglal
Journal of Clinical Epidemiology
|
April 1, 1993
Should there be early publication of ancillary studies prior to the first primary report of an unblinded randomized clinical trial?
D L Sackett, C D Naylor
JAMA
|
February 21, 1996
Users' guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. The Evidence-Based Medicine Working Group
C D Naylor, G H Guyatt
JAMA
|
May 8, 1996
Users' guides to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group
C D Naylor, G H Guyatt
Social Science & Medicine (1982)
|
January 1, 1990
Practice guidelines and professional autonomy in a universal health insurance system: the case of tissue plasminogen activator in Ontario
C D Naylor, A A Hollenberg
Annual Review of Nutrition
|
January 1, 1996
Cholesterol policy and the primary prevention of coronary disease: reflections on clinical and population strategies
C D Naylor, J M Paterson
Journal of Clinical Epidemiology
|
December 1, 1992
How should health status measures be assessed? Cautionary notes on procrustean frameworks
J I Williams, C D Naylor
Page
of 22
Search research articles
Search
Showing results (41-50 of 211) with videos related to
Sort By:
Page
of 22
Lancet (London, England)
|
November 19, 1988
Aspirin and fibrinolysis
A Basinski, C D Naylor
Pharmacoeconomics
|
March 9, 1994
Drug prices and third party payment: do they influence medication selection?
J E Hux, C D Naylor
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 1, 1995
Reflections on supply-demand mismatch in dialysis services in Ontario
N K Choudhry, C D Naylor
The Canadian Journal of Cardiology
|
September 1, 1995
Regional revascularization patterns after myocardial infarction in Ontario
C D Naylor, S B Jaglal
Journal of Clinical Epidemiology
|
April 1, 1993
Should there be early publication of ancillary studies prior to the first primary report of an unblinded randomized clinical trial?
D L Sackett, C D Naylor
JAMA
|
February 21, 1996
Users' guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. The Evidence-Based Medicine Working Group
C D Naylor, G H Guyatt
JAMA
|
May 8, 1996
Users' guides to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group
C D Naylor, G H Guyatt
Social Science & Medicine (1982)
|
January 1, 1990
Practice guidelines and professional autonomy in a universal health insurance system: the case of tissue plasminogen activator in Ontario
C D Naylor, A A Hollenberg
Annual Review of Nutrition
|
January 1, 1996
Cholesterol policy and the primary prevention of coronary disease: reflections on clinical and population strategies
C D Naylor, J M Paterson
Journal of Clinical Epidemiology
|
December 1, 1992
How should health status measures be assessed? Cautionary notes on procrustean frameworks
J I Williams, C D Naylor
Page
of 22